WallStreetZenWallStreetZen

NASDAQ: SPRY
Ars Pharmaceuticals Inc Stock Ownership - Who owns Ars Pharmaceuticals?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Ars Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Richard E. LowenthalPRESIDENT AND CEO2024-04-1650,000$9.28
$464.00kSell
Sarina TanimotoCHIEF MEDICAL OFFICER2024-04-1650,000$9.28
$464.00kSell
Sarina TanimotoCHIEF MEDICAL OFFICER2024-04-1650,000$9.28
$464.00kSell
Richard E. LowenthalPRESIDENT AND CEO2024-04-1650,000$9.28
$464.00kSell
Richard E. LowenthalPRESIDENT AND CEO2024-04-0950,000$9.28
$463.85kSell
Sarina TanimotoCHIEF MEDICAL OFFICER2024-04-0950,000$9.28
$463.85kSell
Richard E. LowenthalPRESIDENT AND CEO2024-04-0950,000$9.28
$463.90kSell
Sarina TanimotoCHIEF MEDICAL OFFICER2024-04-0950,000$9.28
$463.90kSell
Ra Capital Management LPDirector2024-03-27505,954$9.79
$4.95MBuy
Ra Capital Management LPDirector2024-03-26457,745$9.55
$4.37MBuy

1 of 10

SPRY insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SPRY insiders and whales buy or sell their stock.

SPRY Shareholders

What type of owners hold Ars Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Richard E. Lowenthal14.76%14,242,610$120.21MInsider
Sarina Tanimoto14.71%14,192,610$119.79MInsider
James E. Flynn11.48%11,077,928$93.50MInsider
Deerfield Management Company LP Series C11.48%11,077,927$93.50MInstitution
Pratik Shah10.52%10,156,204$85.72MInsider
Orbimed Advisors LLC10.32%9,962,588$84.08MInsider
Peter A. Thompson10.32%9,962,588$84.08MInsider
Ra Capital Management LP9.80%9,459,678$79.84MInstitution
Orbimed Advisors LLC9.58%9,240,887$77.99MInstitution
Jonathan D. Root4.61%4,445,960$37.52MInsider

1 of 3

SPRY vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SPRY43.85%56.15%Net BuyingNet Buying
SAGE71.61%28.39%Net Selling
TYRA59.50%40.50%Net BuyingNet Buying
SAVA28.54%71.46%Net BuyingNet Buying
ETNB85.97%14.03%Net BuyingNet Buying
View Top Biotech Stocks

Ars Pharmaceuticals Stock Ownership FAQ

Who owns Ars Pharmaceuticals?

Ars Pharmaceuticals (NASDAQ: SPRY) is owned by 67.80% institutional shareholders, 86.80% Ars Pharmaceuticals insiders, and 0.00% retail investors. Richard E. Lowenthal is the largest individual Ars Pharmaceuticals shareholder, owning 14.24M shares representing 14.76% of the company. Richard E. Lowenthal's Ars Pharmaceuticals shares are currently valued at $120.63M.

If you're new to stock investing, here's how to buy Ars Pharmaceuticals stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.